Sleep Disorders in Rodent Models of Parkinson’s Disease

Sleep disorders are frequently diagnosed in Parkinson’s disease and manifested in the prodromal and advanced stages of the disease. These conditions, which in some cases affect more than 50% of Parkinson’s disease (PD) patients, include hypersomnia, often manifested as excessive daytime sleepiness,...

Full description

Bibliographic Details
Main Authors: Daniel de Castro Medeiros, Cleiton Lopes Aguiar, Márcio Flávio Dutra Moraes, Gilberto Fisone
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01414/full
_version_ 1819110436930322432
author Daniel de Castro Medeiros
Daniel de Castro Medeiros
Cleiton Lopes Aguiar
Márcio Flávio Dutra Moraes
Gilberto Fisone
author_facet Daniel de Castro Medeiros
Daniel de Castro Medeiros
Cleiton Lopes Aguiar
Márcio Flávio Dutra Moraes
Gilberto Fisone
author_sort Daniel de Castro Medeiros
collection DOAJ
description Sleep disorders are frequently diagnosed in Parkinson’s disease and manifested in the prodromal and advanced stages of the disease. These conditions, which in some cases affect more than 50% of Parkinson’s disease (PD) patients, include hypersomnia, often manifested as excessive daytime sleepiness, insomnia, characterized by delayed initiation and fragmentation of sleep at night, and disruption of rapid eye movement (REM) sleep, resulting in loss of atonia and dream enactment. Standard dopamine replacement therapies for the treatment of motor symptoms are generally inadequate to combat sleep abnormalities, which seriously affect the quality of life of PD patients. Rodent models still represent a major tool for the study of many aspects of PD. They have been primarily designed to eliminate midbrain dopamine neurons and elicit motor impairment, which are the traditional pathological features of PD. However, rodent models are increasingly employed to investigate non-motor symptoms, which are often caused by degenerative processes affecting multiple monoaminergic and peptidergic structures. This review describes how neurotoxic and genetic manipulations of rats and mice have been utilized to reproduce some of the major sleep disturbances associated with PD and to what extent these abnormalities can be linked to nondopaminergic dysfunction, affecting for instance noradrenaline, serotonin, and orexin transmission. Strengths and limitations are discussed, as well as the consistency of results obtained so far, and the need for models that better reproduce the multisystemic neurodegenerative nature of PD, thereby allowing to replicate the complex etiology of sleep-related disorders.
first_indexed 2024-12-22T03:41:42Z
format Article
id doaj.art-2343220b2f884f02b22dfa4cac8f8e9d
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-22T03:41:42Z
publishDate 2019-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-2343220b2f884f02b22dfa4cac8f8e9d2022-12-21T18:40:14ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-11-011010.3389/fphar.2019.01414496911Sleep Disorders in Rodent Models of Parkinson’s DiseaseDaniel de Castro Medeiros0Daniel de Castro Medeiros1Cleiton Lopes Aguiar2Márcio Flávio Dutra Moraes3Gilberto Fisone4Department of Neuroscience, Karolinska Institutet, Stockholm, SwedenNúcleo de Neurociências, Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilNúcleo de Neurociências, Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilNúcleo de Neurociências, Departamento de Fisiologia e Biofísica, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, BrazilDepartment of Neuroscience, Karolinska Institutet, Stockholm, SwedenSleep disorders are frequently diagnosed in Parkinson’s disease and manifested in the prodromal and advanced stages of the disease. These conditions, which in some cases affect more than 50% of Parkinson’s disease (PD) patients, include hypersomnia, often manifested as excessive daytime sleepiness, insomnia, characterized by delayed initiation and fragmentation of sleep at night, and disruption of rapid eye movement (REM) sleep, resulting in loss of atonia and dream enactment. Standard dopamine replacement therapies for the treatment of motor symptoms are generally inadequate to combat sleep abnormalities, which seriously affect the quality of life of PD patients. Rodent models still represent a major tool for the study of many aspects of PD. They have been primarily designed to eliminate midbrain dopamine neurons and elicit motor impairment, which are the traditional pathological features of PD. However, rodent models are increasingly employed to investigate non-motor symptoms, which are often caused by degenerative processes affecting multiple monoaminergic and peptidergic structures. This review describes how neurotoxic and genetic manipulations of rats and mice have been utilized to reproduce some of the major sleep disturbances associated with PD and to what extent these abnormalities can be linked to nondopaminergic dysfunction, affecting for instance noradrenaline, serotonin, and orexin transmission. Strengths and limitations are discussed, as well as the consistency of results obtained so far, and the need for models that better reproduce the multisystemic neurodegenerative nature of PD, thereby allowing to replicate the complex etiology of sleep-related disorders.https://www.frontiersin.org/article/10.3389/fphar.2019.01414/fullsleeprapid eye movement sleepslow wave sleepratmousedisease models
spellingShingle Daniel de Castro Medeiros
Daniel de Castro Medeiros
Cleiton Lopes Aguiar
Márcio Flávio Dutra Moraes
Gilberto Fisone
Sleep Disorders in Rodent Models of Parkinson’s Disease
Frontiers in Pharmacology
sleep
rapid eye movement sleep
slow wave sleep
rat
mouse
disease models
title Sleep Disorders in Rodent Models of Parkinson’s Disease
title_full Sleep Disorders in Rodent Models of Parkinson’s Disease
title_fullStr Sleep Disorders in Rodent Models of Parkinson’s Disease
title_full_unstemmed Sleep Disorders in Rodent Models of Parkinson’s Disease
title_short Sleep Disorders in Rodent Models of Parkinson’s Disease
title_sort sleep disorders in rodent models of parkinson s disease
topic sleep
rapid eye movement sleep
slow wave sleep
rat
mouse
disease models
url https://www.frontiersin.org/article/10.3389/fphar.2019.01414/full
work_keys_str_mv AT danieldecastromedeiros sleepdisordersinrodentmodelsofparkinsonsdisease
AT danieldecastromedeiros sleepdisordersinrodentmodelsofparkinsonsdisease
AT cleitonlopesaguiar sleepdisordersinrodentmodelsofparkinsonsdisease
AT marcioflaviodutramoraes sleepdisordersinrodentmodelsofparkinsonsdisease
AT gilbertofisone sleepdisordersinrodentmodelsofparkinsonsdisease